These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 31539552)

  • 1. PPARα agonist alleviates tumor growth and chemo-resistance associated with the inhibition of glucose metabolic pathway.
    Gou Q; Dong C; Jin J; Liu Q; Lu W; Shi J; Hou Y
    Eur J Pharmacol; 2019 Nov; 863():172664. PubMed ID: 31539552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARα Promotes Cancer Cell Glut1 Transcription Repression.
    You M; Jin J; Liu Q; Xu Q; Shi J; Hou Y
    J Cell Biochem; 2017 Jun; 118(6):1556-1562. PubMed ID: 27918085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells.
    Ding J; Gou Q; Jin J; Shi J; Liu Q; Hou Y
    Eur J Pharmacol; 2019 Aug; 857():172425. PubMed ID: 31150647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
    Wu L; Wang W; Dai M; Li H; Chen C; Wang D
    BMC Cancer; 2019 Dec; 19(1):1166. PubMed ID: 31791289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncoupling protein-2 up-regulation and enhanced cyanide toxicity are mediated by PPARalpha activation and oxidative stress.
    Zhang X; Li L; Prabhakaran K; Zhang L; Leavesley HB; Borowitz JL; Isom GE
    Toxicol Appl Pharmacol; 2007 Aug; 223(1):10-9. PubMed ID: 17573087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
    Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
    Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARα-tr, autonomously regulates proliferative and pro-inflammatory genes.
    Thomas M; Bayha C; Klein K; Müller S; Weiss TS; Schwab M; Zanger UM
    BMC Cancer; 2015 Jun; 15():488. PubMed ID: 26122096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARα).
    Thomas M; Burk O; Klumpp B; Kandel BA; Damm G; Weiss TS; Klein K; Schwab M; Zanger UM
    Mol Pharmacol; 2013 Mar; 83(3):709-18. PubMed ID: 23295386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feedback looping between ChREBP and PPARα in the regulation of lipid metabolism in brown adipose tissues.
    Iizuka K; Wu W; Horikawa Y; Saito M; Takeda J
    Endocr J; 2013; 60(10):1145-53. PubMed ID: 23831548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.
    Nagarajan A; Dogra SK; Sun L; Gandotra N; Ho T; Cai G; Cline G; Kumar P; Cowles RA; Wajapeyee N
    Mol Cell; 2017 Aug; 67(4):685-701.e6. PubMed ID: 28803777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643.
    Edvardsson U; Alexandersson M; Brockenhuus von Löwenhielm H; Nyström AC; Ljung B; Nilsson F; Dahllöf B
    Electrophoresis; 1999; 20(4-5):935-42. PubMed ID: 10344269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-Allose Inhibits Cancer Cell Growth by Reducing GLUT1 Expression.
    Noguchi C; Kamitori K; Hossain A; Hoshikawa H; Katagi A; Dong Y; Sui L; Tokuda M; Yamaguchi F
    Tohoku J Exp Med; 2016 Feb; 238(2):131-41. PubMed ID: 26829886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT1-mediated glucose metabolism.
    Liu YX; Feng JY; Sun MM; Liu BW; Yang G; Bu YN; Zhao M; Wang TJ; Zhang WY; Yuan HF; Zhang XD
    Acta Pharmacol Sin; 2019 Jan; 40(1):122-132. PubMed ID: 29925918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.
    Yoon M; Lee H; Jeong S; Kim JJ; Nicol CJ; Nam KW; Kim M; Cho BG; Oh GT
    Br J Pharmacol; 2003 Apr; 138(7):1295-302. PubMed ID: 12711630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nonthiazolidinedione peroxisome proliferator-activated receptor α/γ dual agonist CG301360 alleviates insulin resistance and lipid dysregulation in db/db mice.
    Jeong HW; Lee JW; Kim WS; Choe SS; Shin HJ; Lee GY; Shin D; Lee JH; Choi EB; Lee HK; Yon GH; Cho B; Kim HR; Choi SH; Chung YS; Park SB; Chung H; Ro S; Kim JB
    Mol Pharmacol; 2010 Nov; 78(5):877-85. PubMed ID: 20724462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
    Wang Y; Yun Y; Wu B; Wen L; Wen M; Yang H; Zhao L; Liu W; Huang S; Wen N; Li Y
    Oncotarget; 2016 Jul; 7(30):47985-47997. PubMed ID: 27351131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor alpha and gamma ligands differentially affect smooth muscle cell proliferation and migration.
    Zahradka P; Wright B; Fuerst M; Yurkova N; Molnar K; Taylor CG
    J Pharmacol Exp Ther; 2006 May; 317(2):651-9. PubMed ID: 16407462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARδ promotes tumor progression via activation of Glut1 and SLC1-A5 transcription.
    Zhang W; Xu Y; Xu Q; Shi H; Shi J; Hou Y
    Carcinogenesis; 2017 Jul; 38(7):748-755. PubMed ID: 28419191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1.
    Grau R; Punzón C; Fresno M; Iñiguez MA
    Biochem J; 2006 Apr; 395(1):81-8. PubMed ID: 16343055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.